Sanofi-Aventis Snaps Up Chattem For $1.9B
Sanofi-Aventis SA will pay about $1.9 billion to acquire U.S. health care and consumer product company Chattem Inc., giving the French pharmaceutical company direct access to the over-the-counter and consumer branded...To view the full article, register now.
Already a subscriber? Click here to view full article